vs

Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

ADAMAS TRUST, INC. is the larger business by last-quarter revenue ($43.2M vs $32.6M, roughly 1.3× RxSight, Inc.). ADAMAS TRUST, INC. runs the higher net margin — 124.0% vs -28.1%, a 152.1% gap on every dollar of revenue. On growth, ADAMAS TRUST, INC. posted the faster year-over-year revenue change (61.6% vs -18.9%). ADAMAS TRUST, INC. produced more free cash flow last quarter ($125.9M vs $-2.3M). Over the past eight quarters, ADAMAS TRUST, INC.'s revenue compounded faster (55.5% CAGR vs 5.1%).

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

ADAM vs RXST — Head-to-Head

Bigger by revenue
ADAM
ADAM
1.3× larger
ADAM
$43.2M
$32.6M
RXST
Growing faster (revenue YoY)
ADAM
ADAM
+80.5% gap
ADAM
61.6%
-18.9%
RXST
Higher net margin
ADAM
ADAM
152.1% more per $
ADAM
124.0%
-28.1%
RXST
More free cash flow
ADAM
ADAM
$128.1M more FCF
ADAM
$125.9M
$-2.3M
RXST
Faster 2-yr revenue CAGR
ADAM
ADAM
Annualised
ADAM
55.5%
5.1%
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADAM
ADAM
RXST
RXST
Revenue
$43.2M
$32.6M
Net Profit
$53.5M
$-9.2M
Gross Margin
77.5%
Operating Margin
-34.8%
Net Margin
124.0%
-28.1%
Revenue YoY
61.6%
-18.9%
Net Profit YoY
270.5%
-54.1%
EPS (diluted)
$0.45
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADAM
ADAM
RXST
RXST
Q4 25
$43.2M
$32.6M
Q3 25
$36.6M
$30.3M
Q2 25
$36.4M
$33.6M
Q1 25
$33.1M
$37.9M
Q4 24
$26.7M
$40.2M
Q3 24
$20.2M
$35.3M
Q2 24
$19.0M
$34.9M
Q1 24
$17.9M
$29.5M
Net Profit
ADAM
ADAM
RXST
RXST
Q4 25
$53.5M
$-9.2M
Q3 25
$44.8M
$-9.8M
Q2 25
$8.5M
$-11.8M
Q1 25
$42.2M
$-8.2M
Q4 24
$-31.4M
$-5.9M
Q3 24
$42.8M
$-6.3M
Q2 24
$-15.6M
$-6.1M
Q1 24
$-57.9M
$-9.1M
Gross Margin
ADAM
ADAM
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
ADAM
ADAM
RXST
RXST
Q4 25
-34.8%
Q3 25
-40.1%
Q2 25
11.7%
-41.6%
Q1 25
-28.2%
Q4 24
-119.0%
-21.5%
Q3 24
-26.1%
Q2 24
-124.7%
-23.9%
Q1 24
-448.8%
-36.2%
Net Margin
ADAM
ADAM
RXST
RXST
Q4 25
124.0%
-28.1%
Q3 25
122.5%
-32.4%
Q2 25
23.4%
-35.0%
Q1 25
127.4%
-21.6%
Q4 24
-117.5%
-14.8%
Q3 24
211.7%
-17.9%
Q2 24
-81.9%
-17.4%
Q1 24
-324.1%
-30.8%
EPS (diluted)
ADAM
ADAM
RXST
RXST
Q4 25
$0.45
$-0.22
Q3 25
$0.36
$-0.24
Q2 25
$-0.04
$-0.29
Q1 25
$0.33
$-0.20
Q4 24
$-0.46
$-0.14
Q3 24
$0.36
$-0.16
Q2 24
$-0.29
$-0.16
Q1 24
$-0.75
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADAM
ADAM
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$210.3M
$228.1M
Total DebtLower is stronger
$735.8M
Stockholders' EquityBook value
$1.4B
$275.7M
Total Assets
$12.6B
$311.8M
Debt / EquityLower = less leverage
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADAM
ADAM
RXST
RXST
Q4 25
$210.3M
$228.1M
Q3 25
$185.3M
$227.5M
Q2 25
$160.4M
$227.5M
Q1 25
$177.1M
$229.3M
Q4 24
$167.4M
$237.2M
Q3 24
$195.1M
$237.1M
Q2 24
$235.5M
$233.3M
Q1 24
$226.9M
$125.4M
Total Debt
ADAM
ADAM
RXST
RXST
Q4 25
$735.8M
Q3 25
$766.6M
Q2 25
$653.0M
Q1 25
$654.4M
Q4 24
$573.2M
Q3 24
$699.4M
Q2 24
$800.7M
Q1 24
$1.0B
Stockholders' Equity
ADAM
ADAM
RXST
RXST
Q4 25
$1.4B
$275.7M
Q3 25
$1.4B
$276.0M
Q2 25
$1.4B
$278.0M
Q1 25
$1.4B
$279.3M
Q4 24
$1.4B
$281.2M
Q3 24
$1.4B
$277.3M
Q2 24
$1.4B
$275.2M
Q1 24
$1.5B
$163.9M
Total Assets
ADAM
ADAM
RXST
RXST
Q4 25
$12.6B
$311.8M
Q3 25
$12.4B
$308.5M
Q2 25
$10.6B
$309.0M
Q1 25
$10.0B
$313.0M
Q4 24
$9.2B
$318.6M
Q3 24
$8.9B
$310.5M
Q2 24
$8.2B
$305.5M
Q1 24
$7.4B
$183.2M
Debt / Equity
ADAM
ADAM
RXST
RXST
Q4 25
0.52×
Q3 25
0.55×
Q2 25
0.47×
Q1 25
0.47×
Q4 24
0.41×
Q3 24
0.48×
Q2 24
0.56×
Q1 24
0.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADAM
ADAM
RXST
RXST
Operating Cash FlowLast quarter
$134.0M
$-1.1M
Free Cash FlowOCF − Capex
$125.9M
$-2.3M
FCF MarginFCF / Revenue
291.6%
-6.9%
Capex IntensityCapex / Revenue
18.9%
3.5%
Cash ConversionOCF / Net Profit
2.50×
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADAM
ADAM
RXST
RXST
Q4 25
$134.0M
$-1.1M
Q3 25
$6.9M
$-1.2M
Q2 25
$39.2M
$-4.4M
Q1 25
$25.8M
$-8.8M
Q4 24
$14.1M
$-4.3M
Q3 24
$-922.0K
$650.0K
Q2 24
$-993.0K
$-4.0M
Q1 24
$-13.1M
$-9.3M
Free Cash Flow
ADAM
ADAM
RXST
RXST
Q4 25
$125.9M
$-2.3M
Q3 25
$-1.8M
Q2 25
$-5.9M
Q1 25
$-9.4M
Q4 24
$-10.6M
$-5.1M
Q3 24
$-8.6M
$-453.0K
Q2 24
$-8.6M
$-5.5M
Q1 24
$-19.1M
$-11.3M
FCF Margin
ADAM
ADAM
RXST
RXST
Q4 25
291.6%
-6.9%
Q3 25
-5.8%
Q2 25
-17.6%
Q1 25
-24.8%
Q4 24
-39.6%
-12.7%
Q3 24
-42.3%
-1.3%
Q2 24
-44.9%
-15.9%
Q1 24
-107.0%
-38.2%
Capex Intensity
ADAM
ADAM
RXST
RXST
Q4 25
18.9%
3.5%
Q3 25
1.9%
Q2 25
4.6%
Q1 25
1.5%
Q4 24
92.3%
2.1%
Q3 24
37.7%
3.1%
Q2 24
39.7%
4.4%
Q1 24
33.5%
6.7%
Cash Conversion
ADAM
ADAM
RXST
RXST
Q4 25
2.50×
Q3 25
0.15×
Q2 25
4.59×
Q1 25
0.61×
Q4 24
Q3 24
-0.02×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADAM
ADAM

Other$19.6M45%
Constructive Loans LLC$14.4M33%
Multifamily$9.1M21%

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons